Compiègne, France, March 20, 2014 P.A.R.I.S SA SCOP is proud to announce the acquisition of its assets by the new company ABLIANCE SAS, a limited company with a capital of 100 000 Euros. Our organization assists worldwide more than 300 clients in their production of antibodies and their development projects. Based on its new financial structure and its 14years expertise, ABLIANCE keeps developing its customers portfolio on the R&D and industrial markets. Meantime, our huge investment plans will accompany the development of our production and control labs for current and future clients. ABLIANCE’s clients are Major healthcare companies and Startups who have heavy regulatory and standardizing requirements. Our scientific expertise and our high level of traceability perfectly match with the future challenges of our clients. Approved by the French Ministry of Research, we are familiar with each customer’s requirement.
View Top Employees from P.A.R.I.S Anticorps| Website | http://www.paris-biotech.com |
| Revenue | $7 million |
| Employees | 10 (9 on RocketReach) |
| Founded | 2000 |
| Industry | Biotechnology |
Looking for a particular P.A.R.I.S Anticorps employee's phone or email?
P.A.R.I.S Anticorps Questions
The P.A.R.I.S Anticorps annual revenue was $7 million in 2023.
9 people are employed at P.A.R.I.S Anticorps.
P.A.R.I.S Anticorps is based in Compiègne, Hauts-De-France.
Top P.A.R.I.S Anticorps Employees
